Abstract: Ovarian carcinoma (OC) is one of the most common gynecological malignancies, with a poor prognosis for patients at advanced stage. Danusertib (Danu) is a pan-inhibitor of the Aurora kinases with unclear anticancer effect and underlying mechanisms in OC treatment. This study aimed to examine the cancer cell killing effect and explore the possible mechanisms with a focus on proliferation, cell cycle progression, apoptosis, autophagy, and epithelial to mesenchymal transition (EMT) in human OC cell lines C13 and A2780cp. The results showed that Danu remarkably inhibited cell proliferation, induced apoptosis and autophagy, and suppressed EMT in both cell lines. Danu arrested cells in G2/M phase and led to an accumulation of polyploidy ...
Journal Article; Review;The multikinase inhibitor sorafenib is, at present, the only drug approved f...
Background Current chemotherapeutic agents based on apoptosis induction are lacking in desired effi-...
Journal Article; Review;The multikinase inhibitor sorafenib is, at present, the only drug approved f...
Ovarian carcinoma (OC) is one of the most common gynecological malignancies, with a poor prognosis f...
Ovarian carcinoma (OC) is one of the most common gynecological malignancies, with a poor prognosis f...
Jin-Ping Li,1,2 Yin-Xue Yang,3 Qi-Lun Liu,1 Zhi-Wei Zhou,2,4 Shu-Ting Pan,2,5 Zhi-Xu He,4 Xueji Zhan...
Chun-Xiu Yuan,1,2 Zhi-Wei Zhou,2,3 Yin-Xue Yang,4 Zhi-Xu He,3 Xueji Zhang,5 Dong Wang,6 Tianxing Yan...
Nedaplatin, a cisplatin analog, was developed to reduce the toxicity of cisplatin, whereas it can be...
Abstract: Statins are cholesterol reduction agents that exhibit anti-cancer activity in several huma...
An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ov...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Cyclin-dependent kinase 5 (CDK5) is a cytoplasmic serine / threonine kinase. Knockdown of CDK5 enhan...
Abstract: Autophagy, a self-defense mechanism, has been found to be associated with drug resistance ...
Molecular targeted therapies have been the focus of recent clinical trials for the treatment of pati...
Postmenopausal women are at a higher risk of ovarian cancer due, in part, to increased levels of gon...
Journal Article; Review;The multikinase inhibitor sorafenib is, at present, the only drug approved f...
Background Current chemotherapeutic agents based on apoptosis induction are lacking in desired effi-...
Journal Article; Review;The multikinase inhibitor sorafenib is, at present, the only drug approved f...
Ovarian carcinoma (OC) is one of the most common gynecological malignancies, with a poor prognosis f...
Ovarian carcinoma (OC) is one of the most common gynecological malignancies, with a poor prognosis f...
Jin-Ping Li,1,2 Yin-Xue Yang,3 Qi-Lun Liu,1 Zhi-Wei Zhou,2,4 Shu-Ting Pan,2,5 Zhi-Xu He,4 Xueji Zhan...
Chun-Xiu Yuan,1,2 Zhi-Wei Zhou,2,3 Yin-Xue Yang,4 Zhi-Xu He,3 Xueji Zhang,5 Dong Wang,6 Tianxing Yan...
Nedaplatin, a cisplatin analog, was developed to reduce the toxicity of cisplatin, whereas it can be...
Abstract: Statins are cholesterol reduction agents that exhibit anti-cancer activity in several huma...
An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ov...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Cyclin-dependent kinase 5 (CDK5) is a cytoplasmic serine / threonine kinase. Knockdown of CDK5 enhan...
Abstract: Autophagy, a self-defense mechanism, has been found to be associated with drug resistance ...
Molecular targeted therapies have been the focus of recent clinical trials for the treatment of pati...
Postmenopausal women are at a higher risk of ovarian cancer due, in part, to increased levels of gon...
Journal Article; Review;The multikinase inhibitor sorafenib is, at present, the only drug approved f...
Background Current chemotherapeutic agents based on apoptosis induction are lacking in desired effi-...
Journal Article; Review;The multikinase inhibitor sorafenib is, at present, the only drug approved f...